冷冻治疗市场：按产品、应用、治疗类型、分销管道和地区，2024-2031 年

冷冻疗法市场评估，2024-2031

人们对非侵入性疼痛管理解决方案的好处的认识不断增强，扩大了市场规模据Verified Market Research 分析师称，冷冻治疗市场的估值将在2024 年突破约10.7192 亿美元，在预测期内预计将达到15,526.2 亿美元。

冷冻疗法市场的快速扩张主要是由于慢性疼痛的盛行率不断上升，促使对有效止痛方案的需求不断增长。因此，预计2024年至2031年市场将以4.74%的复合年增长率成长。

冷冻疗法市场定义/概述

冷冻疗法是一种利用冷和热来缓解疼痛和减少发炎的治疗方法。将采用各种治疗方法，包括冰袋、凝胶袋和冷冻治疗装置，为急性创伤、术后恢復和慢性疼痛状况提供有针对性的疼痛缓解。冷冻疗法在麻木疼痛和减轻肿胀方面的有效性已得到多个医学领域的认可，包括骨科、运动医学和身体復健。

人们对冷冻疗法相关益处的认识不断提高，推动了对非侵入性、无药物疼痛管理解决方案不断增长的需求。运动相关伤害和肌肉骨骼疾病发生率上升，以及更容易患慢性疼痛的人口老化等因素都有助于市场扩张。随着医疗保健专业人士继续认可冷热疗法作为有效的治疗方式，冷热疼痛疗法市场预计将在未来几年显着成长。

慢性疼痛疾病的日益普及对冷冻疗法市场有何影响？

慢性疼痛疾病的日益普及对有效疼痛管理解决方案的需求增加，对冷冻治疗市场产生了重大影响。根据美国疾病管制与预防中心(CDC) 的数据，2019 年，估计有20.4% 的美国成年人（5,020 万人）患有慢性疼痛，7.4% 的成年人（1,960 万人）患有慢性疼痛，影响了他们的生活。人口老化和生活方式问题等多种因素导致慢性疼痛患者数量增加。因此，医疗保健提供者强调了对非侵入性、无药物治疗的需求，促使扩大采用冷疗法和热疗法。

随着患者寻求药物治疗的替代方案，冷冻疗法的治疗益处越来越广泛认可。持续的研究强调冷热疗法在减轻疼痛和发炎方面的有效性，进一步推动市场成长。随着人们认识的不断提高，冷冻疗法的采用预计将会成长并推动整体市场的扩张。

冷冻治疗设备的技术进步如何影响市场成长？

冷冻治疗设备的技术进步透过提高冷痛疗法的有效性和使用者体验来影响市场成长。便携式冷冻治疗机和温控智慧冰袋等创新技术的开发可以实现更有针对性、更有效率的疼痛管理。定时器和行动应用程式等功能的整合使这些设备更易于存取和用户友好。

此外，支持这些先进设备有效性的临床研究提高了它们在医疗实践中的可靠性。随着医疗保健提供者对这些创新技术的瞭解越来越多，他们越来越多地推荐将其用于疼痛管理。这一趋势促使技术先进的冷冻治疗解决方案的市场占有率不断增长，使其成为患者和医疗保健专业人员的首选。

目录

第1章全球冷冻治疗市场：简介

• 市场概况
• 调查范围
• 先决条件

第 2 章执行摘要

第3章 VERIFIED MARKET RESEARCH研究方法

• 数据挖掘
• 验证
• 一次资料
• 数据源列表

第4章全球冷冻治疗市场前景

• 概述
• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 波特的五力模型
• 价值链分析

第5章全球冷冻治疗市场：按产品

• 概述
• 非处方药产品
  • 奶油
  • 凝胶
  • 修补
  • 其他
• 处方药
  • 药品
  • 医疗器材

第6章全球冷冻治疗市场：依应用分类

• 概述
• 肌肉骨骼疾病
• 术后治疗
• 创伤后治疗
• 运动医学

第7章全球冷冻治疗市场：按地区

• 概述
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 亚太其他地区
• 世界其他地区
  • 拉丁美洲
  • 中东/非洲

第8章 全球冷冻治疗市场竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第9章 公司简介

• Breg, Inc
• Beiersdorf AG
• A-ssur HF
• 3M Company
• DJO Finance LLC
• Hisamitsu Pharmaceutical Co., Inc
• Johnson & Johnson
• Medline Industries, Inc
• Rohto Pharmaceutical Co., Ltd
• Sanofi

第10章附录

• 相关研究

Cold Pain Therapy Market Valuation - 2024-2031

Increasing awareness of the benefits of non-invasive pain management solutions is driving the market size of the market. According to the analyst from Verified Market Research, the Cold Pain Therapy Market is estimated to reach a valuation of USD 1552.62 Million over the forecast subjugating around USD 1071.92 Million valued in 2024.

The rapid expansion of the cold pain therapy market is primarily driven by the rising prevalence of chronic pain conditions, which is leading to increased demand for effective pain relief options. It enables the market to grow at aCAGR of 4.74% from 2024 to 2031.

Cold Pain Therapy Market: Definition/ Overview

Cold pain therapy is a treatment method that utilizes cold temperatures to alleviate pain and reduce inflammation. Various modalities, including ice packs, gel packs, and cryotherapy devices, are employed in this therapy to provide targeted pain relief for acute injuries, postoperative recovery, and chronic pain conditions. The effectiveness of cold therapy in numbing pain and minimizing swelling has been recognized across multiple medical disciplines, including orthopedics, sports medicine, and physical rehabilitation.

Increasing demand for non-invasive and drug-free pain management solutions is being driven by a growing awareness of the benefits associated with cold pain therapy. Factors such as the rising incidence of sports-related injuries and musculoskeletal disorders, along with an aging population prone to chronic pain conditions, are contributing to the market's expansion. As healthcare professionals continue to endorse cold therapy as an effective treatment option, the market for cold pain therapy is anticipated to experience significant growth in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What Impact is the Rising Prevalence of Chronic Pain Conditions having on the Cold Pain Therapy Market?

The rising prevalence of chronic pain conditions is significantly impacting the cold pain therapy market by increasing the demand for effective pain management solutions. According to the Centers for Disease Control and Prevention (CDC), in 2019, an estimated 20.4% of U.S. adults (50.2 million) had chronic pain, and 7.4% of adults (19.6 million) had high-impact chronic pain that frequently limited life or work activities. Various factors, including the aging population and lifestyle-related issues, have contributed to the escalation of chronic pain cases. Consequently, the need for non-invasive and drug-free treatment options has been emphasized by healthcare providers, leading to an uptick in the adoption of cold therapy modalities.

As patients seek alternatives to pharmacological treatments, the therapeutic benefits of cold pain therapy are being recognized more widely. Market growth is further supported by ongoing research that highlights the efficacy of cold therapy in reducing pain and inflammation. As awareness increases, the adoption of cold pain therapy is anticipated to grow, thereby driving the overall market expansion.

How are Technological Advancements in Cold Therapy Devices Influencing the Market Growth?

Technological advancements in cold therapy devices are influencing market growth by enhancing the effectiveness and user experience of cold pain therapy. Innovations, such as portable cryotherapy machines and smart ice packs with adjustable temperature controls, have been developed, allowing for more targeted and efficient pain management. The integration of features such as timers and mobile applications has made these devices more accessible and user-friendly.

Furthermore, clinical studies supporting the efficacy of these advanced devices have bolstered their credibility in medical settings. As healthcare providers become more informed about these innovations, recommendations for their use in pain management are being made more frequently. This trend is leading to an increased market share for technologically advanced cold pain therapy solutions, thereby positioning them as preferred choices among patients and healthcare professionals alike.

Category-Wise Acumens

What Factors are Contributing to the Dominance of OTC-Based Products in the Cold Pain Therapy Market?

According to VMR Analyst, the dominance of OTC-based products in the Cold Pain Therapy market is being driven by several key factors. Increasing consumer preference for self-management of pain has resulted in a higher demand for over-the-counter solutions, which are perceived as convenient and accessible. As awareness regarding the benefits of cold therapy for pain relief grows, more individuals are opting for OTC options rather than seeking prescription treatments.

The affordability of these products compared to prescription alternatives has also contributed to their popularity. Furthermore, marketing strategies that highlight the effectiveness of OTC cold therapy products have been widely adopted by manufacturers, thereby increasing visibility in retail settings. The regulatory landscape has supported the proliferation of these products, enabling easier access for consumers. Consequently, OTC-based products are expected to maintain a significant share of the market as consumer habits continue to evolve.

What Trends are Driving the Rapid Growth of Online Pharmacies as a Distribution Channel for Cold Pain Therapy Products?

The rapid growth of online pharmacies as a distribution channel for cold pain therapy products is being propelled by changing consumer behaviors and advancements in e-commerce. Increasing preferences for convenience and accessibility have led to a surge in online shopping for healthcare products, including cold therapy solutions. The COVID-19 pandemic has further accelerated this trend, as more consumers have turned to digital platforms for their healthcare needs to minimize exposure in physical stores.

Online pharmacies are being favored for their ability to provide a wide range of products, often at competitive prices. Enhanced delivery options and user-friendly interfaces have made the purchasing process more efficient, attracting a broader customer base. Additionally, targeted marketing and promotions have been employed by online retailers to capture consumer interest. As a result, the market share of online pharmacies is anticipated to expand significantly, reflecting a fundamental shift in how consumers access cold pain therapy products.

Country/Region-wise Acumens

What Factors are Contributing to North America's Dominance in the Cold Pain Therapy Market?

According to VMR analyst, North America's dominance in the cold pain therapy market is being attributed to several influential factors. High levels of healthcare expenditure in the region have facilitated widespread access to advanced therapeutic options, allowing patients to benefit from various cold pain therapy products. A strong emphasis on research and development by leading healthcare companies has resulted in innovative cold therapy solutions that are highly regarded in clinical settings.

Furthermore, the prevalence of chronic pain conditions and sports-related injuries in North America has created significant demand for effective pain management solutions. The influence of healthcare professionals advocating for non-invasive treatment options has further solidified the market position of cold therapy products. Consequently, North America is expected to retain a substantial share of the cold pain therapy market as consumer awareness and demand continues to grow.

How is the Rapid Growth of the Cold Pain Therapy Market Being Supported by Asia Pacific's Increasing Healthcare Expenditures?

According to VMR analyst, the rapid growth of the cold pain therapy market in the Asia Pacific is being supported by increasing healthcare expenditures and a rising population awareness regarding pain management solutions. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of older persons (aged 65 and above) in the Asia-Pacific region is expected to more than double from 535 million in 2015 to about 1.3 billion by 2050. Economic development in several countries within the region has led to improved healthcare infrastructure, making advanced therapy options more accessible to the general population.

The growing prevalence of chronic pain and injuries due to active lifestyles has heightened the demand for effective and convenient pain relief methods. Furthermore, government initiatives promoting health awareness and access to medical products have bolstered market growth. As consumers increasingly recognize the benefits of cold therapy for pain management, investments in healthcare technologies are being prioritized.

Competitive Landscape

The Cold Pain Therapy Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the cold pain therapy market include:

3M Company

Beiersdorf AG

Breg, Inc.

DJO Finance LLC

Hisamitsu Pharmaceutical Co., Inc.

Johnson & Johnson

Medline Industries, Inc.

Rohto Pharmaceutical Co., Ltd.

Latest Developments

In April 2021, Battle Creek Equipment Co. announced the launch of a line of cold therapy wraps to assist in alleviating chronic pain, acute pain, and inflammation.

In March 2019, Performance Health increased its product offering with the introduction of the Biofreeze pain treatment patch.

In 2019, Performance Health announced the launch of the Cold Patches Biofreeze Pain Relief Patch.

In 2019, DJO Global developed the cooling pads DonJoy IceMan Classic 3.

In February 2021, Breg established announced a partnership with Club Warehouse to enhance the delivery of its high-value orthopedic products in Australia. The company intends to distribute its products throughout the continent, including Australian Football League, National Rugby League, and Rugby Union Clubs.

In December 2020, Sanofi reaffirmed announced a partnership with WHO to combat some neglected diseases and eliminate sleeping sickness by 2030. Sanofi provides a specific amount of financial support for disease management, campaigns, drug donations, and so on. The cooperation is already 20 years old and helps with the screening, control, and treatment of sleeping sickness, one of the most neglected tropical diseases.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COLD PAIN THERAPY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL COLD PAIN THERAPY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL COLD PAIN THERAPY MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 OTC Products
  • 5.2.1 Creams
  • 5.2.2 Gels
  • 5.2.3 Patches
  • 5.2.4 Others
• 5.3 Prescription Products
  • 5.3.1 Pharmaceuticals
  • 5.3.2 Medical Devices

6 GLOBAL COLD PAIN THERAPY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Musculoskeletal Disorders
• 6.3 Post-Operative Therapy
• 6.4 Post-Trauma Therapy
• 6.5 Sports Medicine

7 GLOBAL COLD PAIN THERAPY MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL COLD PAIN THERAPY MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Breg, Inc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Beiersdorf AG
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 A-ssur HF
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 3M Company
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 DJO Finance LLC
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Hisamitsu Pharmaceutical Co., Inc
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Johnson & Johnson
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Medline Industries, Inc
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Rohto Pharmaceutical Co., Ltd
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sanofi
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research